SCHEMBL14950693

SCHEMBL14950693

Cc1cccc(NCc2ccc(CNc3cccc(C(=O)O)c3)cc2)c1

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 15/20 0.62
FFAR1 O14842 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10055040 0.91 FFAR1 (0.68) PPARAFFAR1
SCHEMBL15458722 0.88 HIF1A (0.67) PPARAFFAR1
SCHEMBL2185809 0.86 FFAR1 (0.70) PPARAFFAR1
SCHEMBL2188996 0.84 PPARA (0.79) PPARAFFAR1
SCHEMBL2309613 0.83 PPARA (0.86) PPARAFFAR1
SCHEMBL14758954 0.83 FFAR1 (0.70) PPARAFFAR1
SCHEMBL12581587 0.83 MRGPRX4 (0.73) PPARAFFAR1
SCHEMBL21370449 0.82 PPARA (0.83) PPARAFFAR1
SCHEMBL15761768 0.81 CA1 (0.62) PPARA
SCHEMBL259701 0.81 MAPT (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013070660-A1 TRICYCLIC AMINO CONTAINING COMPOUNDS FOR TREATMENT OR PREVENTION OF SYMPTOMS ASSOCIATED WITH ENDOCRINE DYSFUNCTION EMORY UNIVERSITY (US) 2013-05-16 WO disclosed